Eden Research (LON:EDEN) Shares Climb 22.8% – Should You Buy?

Eden Research plc (LON:EDEN – Get Free Report) shot up 22.8% during mid-day trading on Monday. The company traded as high as GBX 4 and last traded at GBX 3.82. Approximately 4,710,562 shares traded hands during trading, an increase of 710% from the average session volume of 581,391 shares. The stock had previously closed at GBX 3.11.

Eden Research Stock Up 22.8%

The company has a quick ratio of 2.42, a current ratio of 1.95 and a debt-to-equity ratio of 5.41. The firm has a market capitalization of £30.69 million, a price-to-earnings ratio of -8.62 and a beta of 1.55. The stock has a 50 day moving average of GBX 2.34 and a 200 day moving average of GBX 3.04.

Eden Research (LON:EDEN – Get Free Report) last announced its quarterly earnings results on Wednesday, August 26th. The company reported GBX (0.36) earnings per share for the quarter. Eden Research had a negative return on equity of 16.16% and a negative net margin of 50.43%. As a group, analysts expect that Eden Research plc will post -66.00 earnings per share for the current fiscal year.

Eden Research Company Profile

(Get Free Report)

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites. To date, they have been primarily used on high-value fruits and vegetables, improving crop yields and marketability, with equal or better performance when compared with conventional pesticides.

Featured Stories

Receive News & Ratings for Eden Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eden Research and related companies with MarketBeat.com's FREE daily email newsletter.